5 results
424B5
XXII
22nd Century Group Inc
18 Oct 23
Prospectus supplement for primary offering
4:32pm
, neurodegenerative conditions, autoimmune diseases, opioid use disorder, and other serious diseases, without sufficient evidence and the legally
424B5
XXII
22nd Century Group Inc
16 Oct 23
Prospectus supplement for primary offering
4:28pm
diseases, opioid use disorder, and other serious diseases, without sufficient evidence and the legally required FDA approval.”
The agency has
- Prev
- 1
- Next